SCHEMBL21865570

SCHEMBL21865570

CCN(CCN(C(=O)OC(C)(C)C)c1cc(Cl)ccc1C(=O)O)C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHCY P23526 1/20 0.40
TSHR P16473 3/20 0.37
ALDH1A1 P00352 5/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
KDM4E B2RXH2 3/20 0.36
CYP3A4 P08684 2/20 0.36
CASP1 P29466 1/20 0.35
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTT P42858 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
GAA P10253 1/20 0.33
MCOLN3 Q8TDD5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21865558 0.89 ABL1 (0.40) AHCYTSHRALDH1A1SMN1; SMN2MEN1
SCHEMBL28371791 0.88 CYP3A4 (0.44) TSHRALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL21865383 0.86 AHCY (0.41) AHCYTSHRALDH1A1SMN1; SMN2MEN1
SCHEMBL21865385 0.85 AHCY (0.40) AHCYTSHRALDH1A1SMN1; SMN2CYP3A4
SCHEMBL21865632 0.85 PSEN1 (0.45) AHCY
SCHEMBL21865761 0.84 AHCY (0.40) AHCYTSHRALDH1A1SMN1; SMN2CYP3A4
SCHEMBL21865760 0.82 AHCY (0.39) AHCYTSHRALDH1A1SMN1; SMN2MEN1
SCHEMBL21865387 0.79 ALDH1A1 (0.46) AHCYALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL21865379 0.78 NPSR1 (0.38) AHCYSMN1; SMN2MEN1KMT2ACYP3A4
SCHEMBL21865763 0.77 PSEN1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020052509-A1 SULFONAMIDE COMPOUND SERVING AS SODIUM CHANNEL BLOCKER AND USES THEREOF 成都康弘药业集团股份有限公司 2020-03-19 WO disclosed